ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Japan becomes first country to approve Ronapreve (casirivimab and imdevimab) for the treatment of mild to moderate COVID-19
July 26, 2021Roche announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Ronapreve™ (casirivimab and imdevimab), for the treatment of patients with mild to moderate COVID-19 via intravenous infusion. -
Roche’s antibody cocktail lowers hospitalisation by 70% in Covid-19 patients
March 24, 2021Roche has reported that the Phase III REGN-COV 2067 trial of investigational antibody cocktail of casirivimab and imdevimab met its primary endpoint of reducing the risk of hospitalisation or death in treating high-risk, non-hospitalised Covid-19 ...
Pharma Sources Insight January 2025
